SavedAdd your journal

Journals / Turkish Journal of Internal Medicine / 2026 / Volume: 3 Issue: Supplement 1 Special Issue

Pectoral muscle hematoma as a complication of Covid-19 treatment: A Case Report

Yıldız Okuturlar(ACIBADEM MEHMET ALI AYDINLAR UNIVERSITY, SCHOOL OF MEDICINE)0000-0002-1994-0014
Damla Gürleyik(ACIBADEM MEHMET ALI AYDINLAR UNIVERSITY, SCHOOL OF MEDICINE)0000-0002-1675-8831
Nur Ramoğlu(ACIBADEM MEHMET ALI AYDINLAR UNIVERSITY, SCHOOL OF MEDICINE)0000-0002-3748-4649
Yasemin Gündoğdu(ACIBADEM MEHMET ALI AYDINLAR UNIVERSITY, SCHOOL OF MEDICINE)0000-0002-1428-8290
İftihar Köksal(ACIBADEM MEHMET ALI AYDINLAR UNIVERSITY, SCHOOL OF MEDICINE)0000-0003-4892-8935
Pages
—
Publication Date
2021-03-07
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Here we presented a case of COVID-19 who developed a hematoma in the pectoral muscle possibly associated with anticoagulation therapy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In COVID-19 disease, the activation of the coagulation system is increasing.
📊
Key Findings & Data:In COVID-19 disease, the activation of the coagulation system is increasing.
💡
Conclusion & Impact:Here we presented a case of COVID-19 who developed a hematoma in the pectoral muscle possibly associated with anticoagulation therapy.
🔬Design:Case Report
📍Scope:Comprehensive Sample
⚙️Variables:COVID-19 · bleeding · anticoagulation

Abstract

In COVID-19 disease, the activation of the coagulation system is increasing. Here we presented a case of COVID-19 who developed a hematoma in the pectoral muscle possibly associated with anticoagulation therapy.

🔖

Cite This Article

Okuturlar, Y., Gürleyik, D., Ramoğlu, N., Gündoğdu, Y., Köksal, İ. (2021). Pectoral muscle hematoma as a complication of Covid-19 treatment: A Case Report. Turkish Journal of Internal Medicine, Volume: 3 Issue: Supplement 1 Special Issue. https://doi.org/10.46310/tjim.876970

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Frydman, G. H., Streiff, M. B., Connors, J. M., & Piazza, G. The Potential Role of Coagulation Factor Xa in the Pathophysiology of COVID-19: A Role for Anticoagulants as Multimodal Therapeutic Agents. 2020; TH Open, 04(04), e288–e299. doi:10.1055/s-0040-1718415
  2. Unuvar A. COVID-19 and Coagulopathy. Sağlık Bilimlerinde İleri Araştırmalar Dergisi 2020; 3(Suppl.1): S53-S62. https://doi.org/10.26650/JARHS2020-S1-0007
  3. Cuker, Adam, and Flora Peyvandi. “Coronavirus Disease 2019 (COVID-19): Hypercoagulability.” UpToDate, 2020, www.uptodate.com/contents/coronavirus-disease-2019-covid-19-hypercoagulability.